| | | | | | | | | | |
|
|
|
|
| Dockets Entered On
December 19, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1977N-0094L
|
| Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment ot the Tentative Final Monograph; Required Warnings and Other Labeling
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0056
|
| Patient Examination & Surgeons' Gloves; Test Procedures
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2005N-0403
|
| Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
| 2006N-0062
|
| Expanded Access to Investigational Drugs for Treatment Use
|
|
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
|
|
| 2006N-0414
|
| Suicidality Data from Adult Antidepressant Trials
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
|
|
| 2006P-0506
|
| Request that the FDA announce an Advance Notice of Proposed Rulemaking regarding the use of symbols on the principal display panel that would communicate to consumers the healthfulness of foods.
|
|
|
|
|
|
|
|
|
| 2006P-0523
|
| Require ANDA applicant for generic of Eloxatin solution as reference drug perform clinical testing
|
|
|
|
|
| 1977N-0094L
|
| Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment ot the Tentative Final Monograph; Required Warnings and Other Labeling
|
|
|
|
|
|
|
|
|
|
|
| NPR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
|
|
| EC
156
|
| Ms. Christy Scott
|
| Vol #:
|
| 14
|
|
|
|
|
| EC
157
|
| Dr. Ellen Gendler
|
| Vol #:
|
| 14
|
|
|
|
|
| EC
158
|
| American Academy of Dermatology
|
| Vol #:
|
| 14
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| EMC 746
|
| Calorie Control Council
|
| Vol #:
|
| 10
|
|
|
|
|
| EMC 747
|
| B. Martini
|
| Vol #:
|
| 10
|
|
|
|
|
| 2003N-0056
|
| Patient Examination & Surgeons' Gloves; Test Procedures
|
|
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 1399
|
| T. Fletcher
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1400
|
| No Submitter
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1401
|
| V. Eberle
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1402
|
| A. Dunlap
|
| Vol #:
|
| 12
|
|
|
|
|
| EMC 1403
|
| No Submitter
|
| Vol #:
|
| 12
|
|
| | | | | | | | |
|
|
|
|
| EMC 10
|
| J Golian
|
| Vol #:
|
| 13
|
|
|
|
|
| 2006N-0062
|
| Expanded Access to Investigational Drugs for Treatment Use
|
|
|
|
|
| EREG 1
|
| D. Kaylor
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
|
|
| EMC 2
|
| B. Braun Medical, Inc.
|
| Vol #:
|
| 6
|
|
|
|
|
| 2006N-0414
|
| Suicidality Data from Adult Antidepressant Trials
|
|
|
|
|
| EMC 18
|
| R. Cleghorn
|
| Vol #:
|
| 2
|
|
|
|
|
| EMC 19
|
| N. Fredricks
|
| Vol #:
|
| 2
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| EC
449
|
| Ms. Lois Wye
|
| Vol #:
|
| 7
|
|
|
|
|
| EC
450
|
| Ms. Jennifer Demers
|
| Vol #:
|
| 7
|
|
|
|
|
| EC
451
|
| Mrs. Brenda Elizondo
|
| Vol #:
|
| 7
|
|
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
|
|
| EMC 11
|
| C. Brueckner
|
| Vol #:
|
| 2
|
|
|
|
|
| 2006P-0506
|
| Request that the FDA announce an Advance Notice of Proposed Rulemaking regarding the use of symbols on the principal display panel that would communicate to consumers the healthfulness of foods.
|
|
|
|
|
|
|
|
|
|
|
| LET 1
|
| FDA/DDM to Center for Science in the Public Interest
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0523
|
| Require ANDA applicant for generic of Eloxatin solution as reference drug perform clinical testing
|
|
|
|
|
| ACK 1
|
| Sanofi-aventis US LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Sanofi-aventis US LLP
|
| Vol #:
|
| 1
|
|
